Home health tech supplier Birdie has raised £24.7 million in Series B funding, taking the total raised by the company to £42.8 million.
Focusing on the care industry, the company’s mission is to ‘reinvent home healthcare and empower older generations’ by using its software platform. The tech supports care visits by providing digital tools for scheduling visits, creating care plans, preparing audit reports and invoicing to care management, aiming to “facilitate information sharing with health practitioners and care communities for delivering personalised care at home”.
The company has grown three-fold in the past year, and now works with partners including Alina Homecare, Medacs Healthcare and Care at Home Group, supporting millions of personalised home-care visits every month.
Max Parmentier, co-founder and CEO of Birdie, said: “With millions of clinical data points collected each month, we plan on deriving personalised and predictive insights to enable a value-based healthcare delivery model. This latest investment, just over one year from the last round, is not only a validation of Birdie’s growth trajectory, but also an endorsement for the potential of our social impact.”
Harold Boël, CEO of Sofina, added: “The home healthcare tech sector seems ripe for an innovative leader like Birdie to catalyse the necessary social change. Aligned with our strategy to back growing and sustainable businesses, we’re excited to join them on their mission to enrich the lives of millions of older adults through preventive and personalised care at home.”
The funding round was led by Sofina and supported by OMERS Ventures and Index.
In recent funding and acquisition news, HTN reported Optum’s plans to buy EMIS for £1.2billion, and social care innovator Florence raising £28.5 million.
